牛叉诊股

[{"date":"2026.03.27","stock":"6.45","trade":"4.54","ind":"1.13"},{"date":"2026.03.26","stock":"-1.79","trade":"-0.58","ind":"-1.41"},{"date":"2026.03.25","stock":"0.55","trade":"1.24","ind":"1.95"},{"date":"2026.03.24","stock":"4.15","trade":"4.01","ind":"1.43"},{"date":"2026.03.23","stock":"-8.32","trade":"-5.71","ind":"-3.76"},{"date":"2026.03.20","stock":"-2.84","trade":"-2.21","ind":"-0.25"},{"date":"2026.03.19","stock":"-0.65","trade":"-2.44","ind":"-2.02"},{"date":"2026.03.18","stock":"-4.41","trade":"0.78","ind":"1.05"},{"date":"2026.03.17","stock":"-2.76","trade":"-0.82","ind":"-1.87"},{"date":"2026.03.16","stock":"3.45","trade":"0.60","ind":"0.19"},{"date":"2026.03.13","stock":"8.72","trade":"-0.10","ind":"-0.65"},{"date":"2026.03.12","stock":"-2.00","trade":"-0.73","ind":"-0.63"},{"date":"2026.03.11","stock":"-3.28","trade":"-0.51","ind":"0.78"},{"date":"2026.03.10","stock":"1.18","trade":"2.00","ind":"2.04"},{"date":"2026.03.09","stock":"-0.36","trade":"-0.66","ind":"-0.74"},{"date":"2026.03.06","stock":"-1.17","trade":"3.02","ind":"0.59"},{"date":"2026.03.05","stock":"2.44","trade":"1.11","ind":"1.23"},{"date":"2026.03.04","stock":"-1.89","trade":"-0.71","ind":"-0.75"},{"date":"2026.03.03","stock":"-8.79","trade":"-2.60","ind":"-3.07"},{"date":"2026.03.02","stock":"0.37","trade":"-2.57","ind":"-0.20"},{"date":"2026.02.27","stock":"1.33","trade":"0.44","ind":"-0.06"}]

广生堂,深证成指,化学制药指数

压力支撑

该股压力位为99.70元，支撑位为94.15元。

[{"text":"\u538b\u529b\u4f4d","value":"99.70","date":1774540800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"94.15","date":1774540800,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.7资金面打败了27%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：03月27日 20:30

机构今日流向(万元)	4639.64	机构5日流向(万元)	1709.70
机构10日流向(万元)	-2123.33	机构20日流向(万元)	-5815.71

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少4866.61万股，其中基金净增仓1家，主力净减仓29家，暂未发现中长期投资价值。

截止2025-12-31，共2家主力机构（基金2家），持仓量总计6.3万股，占流通A股0.05%
其中，基金持仓与2025-06-30相比：
增仓：1家，增持 2.49万股
减仓：0家，减持 0万股
新出现在主力名单中：1家，持有1.15万股
从主力名单中消失：30家，原持有4870.25万股

消息面诊股

诊断结果：1.1消息面打败了0%的股票今日有利好新闻的公司

近期该股利空消息较多，投资时需谨慎。

消息面得分最高的股票

消息列表

重大利空	业绩预告	预计增亏	2026-01-31
一般消息	高管变动	取消监事会	2025-11-21
一般消息	股东大会	临时股东大会	2025-10-30
一般消息	分红转增	不分配不转增	2025-08-22
一般消息	重大事项	公司股东股份解押	2025-05-08
一般消息	分红转增	不分配不转增	2025-04-18
一般消息	高管变动	因个人原因	2025-04-02

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	1条	0条

行业面诊股

诊断结果：3.2行业面打败了54%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2026.03.27","price":"1.13","value":"4.54"},{"date":"2026.03.26","price":"-1.41","value":"-0.58"},{"date":"2026.03.25","price":"1.95","value":"1.24"},{"date":"2026.03.24","price":"1.43","value":"4.01"},{"date":"2026.03.23","price":"-3.76","value":"-5.71"},{"date":"2026.03.20","price":"-0.25","value":"-2.21"},{"date":"2026.03.19","price":"-2.02","value":"-2.44"},{"date":"2026.03.18","price":"1.05","value":"0.78"},{"date":"2026.03.17","price":"-1.87","value":"-0.82"},{"date":"2026.03.16","price":"0.19","value":"0.60"},{"date":"2026.03.13","price":"-0.65","value":"-0.10"},{"date":"2026.03.12","price":"-0.63","value":"-0.73"},{"date":"2026.03.11","price":"0.78","value":"-0.51"},{"date":"2026.03.10","price":"2.04","value":"2.00"},{"date":"2026.03.09","price":"-0.74","value":"-0.66"},{"date":"2026.03.06","price":"0.59","value":"3.02"},{"date":"2026.03.05","price":"1.23","value":"1.11"},{"date":"2026.03.04","price":"-0.75","value":"-0.71"},{"date":"2026.03.03","price":"-3.07","value":"-2.60"},{"date":"2026.03.02","price":"-0.20","value":"-2.57"},{"date":"2026.02.27","price":"-0.06","value":"0.44"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	美诺华	75.07%	40.73%	6.3分
2	ST景峰	74.22%	26.55%	6.0分
3	信立泰	26.00%	6.51%	6.4分
4	泽璟制药	22.61%	16.45%	6.0分
5	联环药业	22.30%	14.13%	6.1分
6	华纳药厂	21.71%	23.24%	5.9分
7	海思科	18.20%	8.05%	6.3分
8	富祥药业	16.97%	27.61%	5.6分
9	上海谊众	15.30%	11.06%	6.8分
10	科伦药业	14.34%	1.60%	6.3分
11	亚虹医药	11.93%	-0.58%	4.3分
12	苑东生物	10.63%	13.80%	6.8分
13	迪哲医药	10.02%	15.13%	6.2分
14	新和成	9.37%	0.58%	5.3分
15	力生制药	9.36%	9.36%	6.6分
16	百利天恒	8.38%	5.64%	6.1分
17	博瑞医药	8.10%	3.64%	5.5分
18	海森药业	6.83%	15.29%	5.3分
19	首药控股	4.92%	6.01%	5.6分
20	舒泰神	4.91%	15.43%	6.4分
21	宏源药业	4.69%	14.48%	6.4分
22	艾力斯	4.41%	7.28%	6.4分
23	*ST三圣	4.14%	3.19%	4.6分
24	司太立	4.01%	14.14%	6.0分
25	诚意药业	3.35%	4.79%	6.5分
26	吉贝尔	3.27%	0.24%	5.2分
27	奥翔药业	3.19%	8.90%	6.0分
28	润都股份	3.00%	6.32%	6.1分
29	翰宇药业	2.51%	4.10%	6.4分
30	双鹭药业	2.32%	13.38%	4.9分
31	津药药业	1.64%	8.25%	5.9分
32	海辰药业	0.89%	11.83%	5.6分
33	奥锐特	0.53%	2.85%	6.4分
34	华润双鹤	0.49%	-0.86%	6.3分
35	奥赛康	0.26%	7.85%	5.5分
36	东北制药	-0.19%	2.35%	5.6分
37	莱美药业	-0.20%	7.87%	5.8分
38	川宁生物	-0.79%	2.55%	5.7分
39	东诚药业	-1.05%	1.70%	5.7分
40	华海药业	-1.06%	3.40%	5.7分
41	华东医药	-1.28%	1.46%	6.2分
42	复星医药	-1.32%	5.11%	6.4分
43	*ST赛隆	-1.46%	-4.24%	4.5分
44	海正药业	-1.73%	-0.68%	5.4分
45	亿帆医药	-1.80%	-1.58%	4.9分
46	华特达因	-1.92%	-3.09%	4.9分
47	一品红	-2.05%	3.70%	5.6分
48	拓新药业	-2.05%	3.58%	4.6分
49	健友股份	-2.12%	-1.32%	5.7分
50	新诺威	-2.27%	7.03%	5.4分
51	中关村	-2.29%	2.00%	5.8分
52	西点药业	-2.30%	5.51%	5.2分
53	浙江医药	-2.39%	4.61%	5.4分
54	恒瑞医药	-2.44%	0.07%	6.3分
55	必贝特	-2.55%	3.39%	6.1分
56	ST天圣	-2.63%	0.39%	5.4分
57	普洛药业	-2.88%	6.23%	5.3分
58	天新药业	-2.95%	-3.37%	5.1分
59	盟科药业	-3.00%	1.82%	5.7分
60	罗欣药业	-3.04%	2.80%	5.6分
61	国药现代	-3.09%	-0.58%	5.8分
62	誉衡药业	-3.16%	5.31%	6.6分
63	灵康药业	-3.22%	3.92%	5.7分
64	共同药业	-3.23%	3.55%	4.8分
65	哈药股份	-3.40%	-0.87%	5.4分
66	北大医药	-3.43%	3.32%	5.7分
67	千红制药	-3.59%	3.87%	5.7分
68	海欣股份	-3.61%	0.76%	5.1分
69	昂利康	-3.74%	7.41%	6.0分
70	丽珠集团	-3.87%	-0.55%	5.6分
71	健康元	-4.19%	0.18%	5.7分
72	国邦医药	-4.28%	2.40%	5.5分
73	华北制药	-4.48%	-1.84%	5.1分
74	哈三联	-4.50%	2.19%	4.6分
75	赛托生物	-4.64%	1.50%	5.0分
76	仙琚制药	-4.79%	-0.11%	5.2分
77	北陆药业	-4.84%	-1.21%	5.8分
78	华仁药业	-4.86%	1.95%	6.1分
79	辰欣药业	-4.87%	2.98%	5.4分
80	金陵药业	-4.91%	0.99%	5.2分
81	丰原药业	-5.02%	2.39%	5.5分
82	亚太药业	-5.09%	6.01%	5.9分
83	京新药业	-5.26%	2.38%	5.6分
84	河化股份	-5.47%	3.96%	5.2分
85	同和药业	-5.49%	1.15%	5.2分
86	易明医药	-5.64%	3.68%	5.7分
87	福元医药	-5.67%	5.53%	6.5分
88	溢多利	-5.69%	-3.63%	4.2分
89	立方制药	-5.83%	2.60%	6.0分
90	山河药辅	-5.83%	1.78%	6.2分
91	亨迪药业	-5.85%	2.72%	4.7分
92	贝达药业	-5.91%	1.60%	5.6分
93	新华制药	-5.92%	1.43%	5.7分
94	ST人福	-6.00%	-0.27%	5.9分
95	恩华药业	-6.01%	1.13%	5.6分
96	前沿生物	-6.08%	8.92%	5.5分
97	华邦健康	-6.12%	2.15%	5.2分
98	卫信康	-6.14%	1.35%	5.8分
99	益方生物	-6.33%	13.07%	6.0分
100	能特科技	-6.50%	3.12%	5.2分
101	永安药业	-6.84%	2.43%	5.1分
102	金城医药	-7.07%	0.78%	5.2分
103	键凯科技	-7.28%	-1.12%	5.6分
104	海普瑞	-7.49%	1.09%	5.0分
105	莎普爱思	-7.72%	0.73%	5.3分
106	宣泰医药	-7.78%	0.53%	5.2分
107	东亚药业	-7.80%	3.63%	4.9分
108	金石亚药	-7.89%	1.74%	5.6分
109	海创药业	-7.90%	4.79%	5.2分
110	微芯生物	-7.98%	2.39%	6.0分
111	神奇制药	-8.10%	3.26%	5.9分
112	复旦张江	-8.18%	1.92%	4.7分
113	本立科技	-8.23%	-1.04%	5.0分
114	天宇股份	-8.24%	6.00%	6.0分
115	福安药业	-8.30%	0.25%	4.5分
116	小方制药	-8.30%	-0.11%	5.0分
117	新天地	-8.35%	-0.51%	4.6分
118	民生健康	-8.50%	1.20%	4.7分
119	仟源医药	-8.88%	-2.10%	5.4分
120	海南海药	-8.96%	4.77%	5.6分
121	兴齐眼药	-9.08%	-2.40%	5.5分
122	威尔药业	-9.20%	-0.16%	5.8分
123	汇宇制药	-9.37%	7.12%	5.1分
124	富士莱	-9.48%	-1.49%	4.8分
125	鲁抗医药	-9.50%	-1.31%	4.8分
126	南新制药	-9.53%	2.67%	4.6分
127	百济神州	-9.71%	2.25%	5.7分
128	尔康制药	-9.77%	6.43%	5.0分
129	九典制药	-9.82%	-1.34%	4.7分
130	康芝药业	-10.08%	2.19%	5.1分
131	ST诺泰	-10.10%	-3.70%	4.9分
132	向日葵	-10.11%	3.72%	5.1分
133	广济药业	-10.19%	2.84%	5.8分
134	德展健康	-10.80%	2.97%	4.5分
135	-	-11.32%	0.25%	分
136	多瑞医药	-11.41%	-15.61%	4.0分
137	海翔药业	-11.48%	6.54%	5.9分
138	圣诺生物	-11.85%	-2.79%	5.4分
139	广生堂	-11.99%	0.39%	4.0分
140	-	-12.02%	-1.01%	分
141	-	-12.18%	-3.23%	分
142	-	-12.31%	-1.61%	分
143	科源制药	-13.47%	-19.92%	4.2分
144	-	-13.51%	-2.75%	分
145	赛分科技	-13.72%	-0.52%	6.4分
146	ST复华	-13.75%	-2.93%	4.2分
147	纳微科技	-13.83%	2.75%	5.2分
148	-	-13.85%	-3.40%	分
149	通化金马	-13.95%	0.41%	5.3分
150	悦康药业	-14.24%	-1.40%	5.0分
151	-	-14.27%	-2.64%	分
152	-	-14.31%	-4.55%	分
153	-	-14.73%	0.00%	分
154	汉商集团	-16.38%	0.57%	5.2分
155	泰恩康	-17.14%	-1.63%	4.2分
156	常山药业	-17.36%	0.71%	4.5分
157	花园生物	-17.93%	0.71%	5.0分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.9基本面打败了15%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 142/218 ， 43/218。

[{"date":"2025-09-30","value":"-30.03","vol":"1.51"},{"date":"2025-06-30","value":"-20.43","vol":"1.23"},{"date":"2025-03-31","value":"-8.24","vol":"-0.14"},{"date":"2024-12-31","value":"-35.66","vol":"19.62"},{"date":"2024-09-30","value":"-14.68","vol":"4.62"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-30.03	-20.43	-8.24	-35.66	-14.68
行业(%)	1.51	1.23	-0.14	19.62	4.62

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"61.91","vol":"49.36"},{"date":"2025-06-30","value":"61.09","vol":"49.33"},{"date":"2025-03-31","value":"65.63","vol":"49.14"},{"date":"2024-12-31","value":"62.09","vol":"50.78"},{"date":"2024-09-30","value":"61.12","vol":"50.61"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	61.91	61.09	65.63	62.09	61.12
行业(%)	49.36	49.33	49.14	50.78	50.61

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 78/218 ， 118/218。

[{"date":"2025-09-30","value":"-3.21","vol":"142.98"},{"date":"2025-06-30","value":"-4.27","vol":"79.25"},{"date":"2025-03-31","value":"-18.69","vol":"-0.67"},{"date":"2024-12-31","value":"4.43","vol":"18.07"},{"date":"2024-09-30","value":"16.67","vol":"45.94"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-3.21	-4.27	-18.69	4.43	16.67
行业(%)	142.98	79.25	-0.67	18.07	45.94

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-57.96","vol":"-3.26"},{"date":"2025-06-30","value":"-85.05","vol":"58.57"},{"date":"2025-03-31","value":"-94.56","vol":"-11.22"},{"date":"2024-12-31","value":"55.16","vol":"-22.02"},{"date":"2024-09-30","value":"63.93","vol":"-34.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-57.96	-85.05	-94.56	55.16	63.93
行业(%)	-3.26	58.57	-11.22	-22.02	-34.66

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 104/218 ， 116/218。

[{"date":"2025-09-30","value":"0.21","vol":"0.31"},{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.07","vol":"0.10"},{"date":"2024-12-31","value":"0.29","vol":"0.43"},{"date":"2024-09-30","value":"0.21","vol":"0.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.21	0.15	0.07	0.29	0.21
行业(次)	0.31	0.21	0.10	0.43	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.93","vol":"1.94"},{"date":"2025-06-30","value":"0.62","vol":"1.30"},{"date":"2025-03-31","value":"0.28","vol":"0.66"},{"date":"2024-12-31","value":"1.48","vol":"3.19"},{"date":"2024-09-30","value":"0.99","vol":"2.12"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.93	0.62	0.28	1.48	0.99
行业(次)	1.94	1.30	0.66	3.19	2.12

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-24.06","vol":"4.43"},{"date":"2025-06-30","value":"-6.13","vol":"2.74"},{"date":"2025-03-31","value":"-12.86","vol":"-26.98"},{"date":"2024-12-31","value":"33.13","vol":"-373.99"},{"date":"2024-09-30","value":"4.65","vol":"-9.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-24.06	-6.13	-12.86	33.13	4.65
行业	4.43	2.74	-26.98	-373.99	-9.47

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.30","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.66","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.30	-	0.66	-
行业	0.00	1.73	0.00	2.00	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 75/218 ， 43/218。

[{"date":"2025-09-30","value":"1.03","vol":"3.50"},{"date":"2025-06-30","value":"0.67","vol":"3.69"},{"date":"2025-03-31","value":"0.69","vol":"3.61"},{"date":"2024-12-31","value":"0.71","vol":"3.36"},{"date":"2024-09-30","value":"0.79","vol":"3.67"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.03	0.67	0.69	0.71	0.79
行业	3.50	3.69	3.61	3.36	3.67

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.62","vol":"2.75"},{"date":"2025-06-30","value":"0.30","vol":"2.90"},{"date":"2025-03-31","value":"0.35","vol":"2.83"},{"date":"2024-12-31","value":"0.38","vol":"2.65"},{"date":"2024-09-30","value":"0.35","vol":"2.93"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	0.62	0.30	0.35	0.38	0.35
行业	2.75	2.90	2.83	2.65	2.93

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 67/218 ， 5/218。

[{"date":"2025-09-30","value":"69.18","vol":"33.63"},{"date":"2025-06-30","value":"76.15","vol":"33.66"},{"date":"2025-03-31","value":"73.45","vol":"33.90"},{"date":"2024-12-31","value":"72.42","vol":"34.07"},{"date":"2024-09-30","value":"67.28","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	69.18	76.15	73.45	72.42	67.28
行业(%)	33.63	33.66	33.90	34.07	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.74","vol":"0.94"},{"date":"2025-06-30","value":"3.55","vol":"0.88"},{"date":"2025-03-31","value":"3.06","vol":"1.47"},{"date":"2024-12-31","value":"2.89","vol":"0.84"},{"date":"2024-09-30","value":"2.28","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	2.74	3.55	3.06	2.89	2.28
行业(%)	0.94	0.88	1.47	0.84	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"-0.35","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.49","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[广生堂]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]